Published in Mamm Genome on March 25, 2011
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med (2008) 17.65
Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature (2006) 13.86
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet (2005) 12.98
Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J (1954) 11.13
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet (2004) 9.68
Bioavailability of curcumin: problems and promises. Mol Pharm (2007) 8.72
Qinghaosu (artemisinin): the price of success. Science (2008) 8.25
The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med (1976) 7.89
Artemisinins target the SERCA of Plasmodium falciparum. Nature (2003) 7.72
Epidemiology of drug-resistant malaria. Lancet Infect Dis (2002) 7.59
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother (1997) 7.36
Malaria: progress, perils, and prospects for eradication. J Clin Invest (2008) 6.54
Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol (2010) 6.28
How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet (2005) 5.79
Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg (2007) 4.58
Identification of an antimalarial synthetic trioxolane drug development candidate. Nature (2004) 4.57
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol (2009) 3.84
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol (2001) 3.84
Immunological processes in malaria pathogenesis. Nat Rev Immunol (2005) 3.80
Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature (1992) 3.67
Artemisinin-resistant malaria in Asia. N Engl J Med (2009) 3.58
Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med (2002) 3.29
Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev (2009) 3.26
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev (1996) 3.26
Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol (2002) 2.91
Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature (2001) 2.87
Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy? Lancet Infect Dis (2009) 2.46
Cysteine proteases of malaria parasites. Int J Parasitol (2004) 2.40
That was then but this is now: malaria research in the time of an eradication agenda. Science (2010) 2.23
Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int (2009) 2.11
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs (1993) 1.95
Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci U S A (1999) 1.91
Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum. Antimicrob Agents Chemother (2010) 1.90
Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J (2001) 1.83
Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science (2009) 1.77
Nephropathic cystinosis: late complications of a multisystemic disease. Pediatr Nephrol (2008) 1.72
Pyruvate kinase deficiency and malaria. N Engl J Med (2008) 1.72
Reaction of antimalarial endoperoxides with specific parasite proteins. Antimicrob Agents Chemother (1994) 1.68
The antiviral activities of artemisinin and artesunate. Clin Infect Dis (2008) 1.55
Studies in haemoglobin E beta-thalassaemia. Br J Haematol (2008) 1.53
Alpha(+)-thalassemia protects African children from severe malaria. Blood (2004) 1.52
Curcumin-artemisinin combination therapy for malaria. Antimicrob Agents Chemother (2006) 1.51
Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother (1993) 1.50
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest (2006) 1.44
Artemisinin derivatives for treating uncomplicated malaria. Cochrane Database Syst Rev (2000) 1.40
Ovalocytosis and cerebral malaria. Nature (1995) 1.40
Pyruvate kinase deficiency in mice protects against malaria. Nat Genet (2003) 1.38
Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol Cell Biol (2004) 1.35
Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr Opin Infect Dis (2007) 1.32
Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice. FEBS Lett (2000) 1.32
Curcumin for malaria therapy. Biochem Biophys Res Commun (2005) 1.28
Erythrocyte variants and the nature of their malaria protective effect. Cell Microbiol (2005) 1.22
Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med (2009) 1.21
Genetic control of resistance to human malaria. Curr Opin Immunol (2009) 1.20
Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. J Exp Med (2007) 1.16
Plasmodium falciparum-infected red blood cells depend on a functional glutathione de novo synthesis attributable to an enhanced loss of glutathione. Biochem J (2000) 1.16
Insights into the immunopathogenesis of malaria using mouse models. Expert Rev Mol Med (2006) 1.16
Vanin genes are clustered (human 6q22-24 and mouse 10A2B1) and encode isoforms of pantetheinase ectoenzymes. Immunogenetics (2001) 1.15
Getting infectious: formation and maturation of Plasmodium sporozoites in the Anopheles vector. Cell Microbiol (2006) 1.14
Genome-wide linkage analysis of malaria infection intensity and mild disease. PLoS Genet (2007) 1.13
Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores. J Clin Invest (2004) 1.13
Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusion. Br J Clin Pharmacol (2007) 1.12
Genetic variability in response to infection: malaria and after. Genes Immun (2002) 1.10
Bioavailable iron and heme metabolism in Plasmodium falciparum. Curr Top Microbiol Immunol (2005) 1.05
Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model. Antimicrob Agents Chemother (2009) 1.05
Heritability of the human infectious reservoir of malaria parasites. PLoS One (2010) 1.00
The mode of action of the antimalarial artemisinin and its derivatives. Gen Pharmacol (1996) 0.99
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease. J Neurochem (2005) 0.97
Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS One (2009) 0.96
Major effect genes or loose confederations? The development of insecticide resistance in the malaria vector Anopheles gambiae. Parasit Vectors (2010) 0.95
Twice-daily cysteamine bitartrate therapy for children with cystinosis. J Pediatr (2010) 0.94
Clinical and molecular aspects of nephropathic cystinosis. J Mol Med (Berl) (1998) 0.94
Genetic and genomic analyses of host-pathogen interactions in malaria. Trends Parasitol (2009) 0.92
Development of artemisinin and its structurally simplified trioxane derivatives as antimalarial drugs. Acta Trop (2004) 0.92
Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model. Inflamm Bowel Dis (2010) 0.91
Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study. Br J Clin Pharmacol (2010) 0.89
A pilot study of the therapeutic efficacy and mechanism of artesunate in the MRL/lpr murine model of systemic lupus erythematosus. Cell Mol Immunol (2009) 0.88
Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases. J Neurochem (2010) 0.87
Genetic resistance to malaria in mouse models. Trends Parasitol (2005) 0.87
Adenosine triphosphate depletion of erythrocytes simulates the phenotype associated with pyruvate kinase deficiency and confers protection against Plasmodium falciparum in vitro. J Infect Dis (2009) 0.86
Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin. Antimicrob Agents Chemother (2010) 0.84
Plasmodium chabaudi: efficacy of artemisinin + curcumin combination treatment on a clone selected for artemisinin resistance in mice. Exp Parasitol (2008) 0.83
Cystamine restores GSTA3 levels in Vanin-1 null mice. Free Radic Biol Med (2007) 0.82
Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium. Exp Parasitol (2010) 0.82
Mapping of Char10, a novel malaria susceptibility locus on mouse chromosome 9. Genes Immun (2009) 0.82
Pyruvate kinase deficiency: correlation between enzyme activity, extent of hemolytic anemia and protection against malaria in independent mouse mutants. Blood Cells Mol Dis (2007) 0.81
Atovaquone/proguanil for the prophylaxis and treatment of malaria. Expert Rev Anti Infect Ther (2005) 0.80
Advances in the management of cerebral malaria in adults. Curr Opin Neurol (2009) 0.79
Drug shows potential for treatment of Huntington's disease. Lancet Neurol (2006) 0.77
In vitro enzymatic conversion of pantothenylcysteine-4'-phosphate into cysteamine. Ital J Biochem (1976) 0.76
Antimicrobial drug discovery through bacteriophage genomics. Nat Biotechnol (2004) 4.17
Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity (2010) 3.96
The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc Natl Acad Sci U S A (2005) 3.84
Mutations in VANGL1 associated with neural-tube defects. N Engl J Med (2007) 3.58
IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med (2011) 3.29
Birc1e is the gene within the Lgn1 locus associated with resistance to Legionella pneumophila. Nat Genet (2002) 2.83
Comparative genomic analysis of 18 Pseudomonas aeruginosa bacteriophages. J Bacteriol (2006) 2.18
Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science (2012) 2.06
Genetic interaction between members of the Vangl family causes neural tube defects in mice. Proc Natl Acad Sci U S A (2008) 1.90
Independent mutations in mouse Vangl2 that cause neural tube defects in looptail mice impair interaction with members of the Dishevelled family. J Biol Chem (2004) 1.90
The Nod-like receptor family member Naip5/Birc1e restricts Legionella pneumophila growth independently of caspase-1 activation. J Immunol (2007) 1.89
A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. J Exp Med (2005) 1.74
NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol (2008) 1.73
Pyruvate kinase deficiency and malaria. N Engl J Med (2008) 1.72
Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood (2003) 1.63
Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria. PLoS Pathog (2013) 1.59
Proteomic analysis of Salmonella enterica serovar typhimurium isolated from RAW 264.7 macrophages: identification of a novel protein that contributes to the replication of serovar typhimurium inside macrophages. J Biol Chem (2006) 1.55
The conserved glutamate residue adjacent to the Walker-B motif is the catalytic base for ATP hydrolysis in the ATP-binding cassette transporter BmrA. J Biol Chem (2003) 1.40
Host-pathogen interactions: Host resistance factor Nramp1 up-regulates the expression of Salmonella pathogenicity island-2 virulence genes. Proc Natl Acad Sci U S A (2002) 1.39
A common genetic fingerprint in leprosy and Crohn's disease? N Engl J Med (2009) 1.39
Pyruvate kinase deficiency in mice protects against malaria. Nat Genet (2003) 1.38
C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med (2008) 1.38
Visualization of vacuolar acidification-induced transcription of genes of pathogens inside macrophages. Mol Biol Cell (2005) 1.37
Novel mutations in VANGL1 in neural tube defects. Hum Mutat (2009) 1.37
Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med (2003) 1.37
Van Gogh-like2 (Strabismus) and its role in planar cell polarity and convergent extension in vertebrates. Trends Genet (2004) 1.36
Comparative studies of duodenal and macrophage ferroportin proteins. Am J Physiol Gastrointest Liver Physiol (2005) 1.25
A new class of small molecule RNA polymerase inhibitors with activity against rifampicin-resistant Staphylococcus aureus. Bioorg Med Chem (2006) 1.23
Erythrocyte variants and the nature of their malaria protective effect. Cell Microbiol (2005) 1.22
Icsbp1/IRF-8 is required for innate and adaptive immune responses against intracellular pathogens. J Immunol (2007) 1.18
Birc1e/Naip5 rapidly antagonizes modulation of phagosome maturation by Legionella pneumophila. Cell Microbiol (2006) 1.17
Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. J Exp Med (2007) 1.16
Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain. Infect Immun (2004) 1.15
Nramp1 modifies the fusion of Salmonella typhimurium-containing vacuoles with cellular endomembranes in macrophages. J Biol Chem (2001) 1.15
Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med (2013) 1.14
Nramp1 expression by dendritic cells modulates inflammatory responses during Salmonella Typhimurium infection. Cell Microbiol (2008) 1.13
Evidence for additive and interaction effects of host genotype and infection in malaria. Proc Natl Acad Sci U S A (2012) 1.11
Naip5/Birc1e and susceptibility to Legionella pneumophila. Trends Microbiol (2005) 1.11
Restriction of Legionella pneumophila replication in macrophages requires concerted action of the transcriptional regulators Irf1 and Irf8 and nod-like receptors Naip5 and Nlrc4. Infect Immun (2009) 1.08
Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs. Proc Natl Acad Sci U S A (2003) 1.07
Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens. Diabetes (2008) 1.06
Dynamic traffic through the recycling compartment couples the metal transporter Nramp2 (DMT1) with the transferrin receptor. J Biol Chem (2003) 1.06
Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells. Cancer Res (2008) 1.05
Expression and subcellular localization of NRAMP1 in human neutrophil granules. Blood (2002) 1.05
TB: screening for responses to a vile visitor. Cell (2010) 1.05
Mutations in the planar cell polarity gene, Fuzzy, are associated with neural tube defects in humans. Hum Mol Genet (2011) 1.04
Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8. J Immunol (2009) 1.04
Fibrotic response as a distinguishing feature of resistance and susceptibility to pulmonary infection with Mycobacterium tuberculosis in mice. Infect Immun (2007) 1.04
Opsonin-independent phagocytosis: an effector mechanism against acute blood-stage Plasmodium chabaudi AS infection. J Infect Dis (2002) 1.04
Iron transport by Nramp2/DMT1: pH regulation of transport by 2 histidines in transmembrane domain 6. Blood (2003) 1.03
Carboxyl-terminus determinants of the iron transporter DMT1/SLC11A2 isoform II (-IRE/1B) mediate internalization from the plasma membrane into recycling endosomes. Biochemistry (2005) 1.02
Distinct targeting and recycling properties of two isoforms of the iron transporter DMT1 (NRAMP2, Slc11A2). Biochemistry (2006) 1.02
Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet (2011) 1.02
Expression of the iron transporter DMT1 in kidney from normal and anemic mk mice. Kidney Int (2002) 1.01
Cerebral malaria: human versus mouse studies. Trends Parasitol (2010) 1.01
Effect of Nramp1 on bacterial replication and on maturation of Mycobacterium avium-containing phagosomes in bone marrow-derived mouse macrophages. Cell Microbiol (2002) 1.00
VANGL1 rare variants associated with neural tube defects affect convergent extension in zebrafish. Mech Dev (2010) 0.99
Primitive neuroectodermal tumor of the stomach. Arch Pathol Lab Med (2005) 0.98
Host resistance to malaria: using mouse models to explore the host response. Mamm Genome (2010) 0.98
Genetic control of myeloproliferation in BXH-2 mice. Blood (2003) 0.98
Molecular and cellular mechanisms underlying neural tube defects in the loop-tail mutant mouse. Biochemistry (2010) 0.97
Pyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in mice. J Exp Med (2007) 0.97
Host immune response to Salmonella enterica serovar Typhimurium infection in mice derived from wild strains. Infect Immun (2002) 0.95
Genetic control of susceptibility to bacterial infections in mouse models. Cell Microbiol (2003) 0.94
Loss of membrane targeting of Vangl proteins causes neural tube defects. Biochemistry (2011) 0.93
Single gene effects in mouse models of host: pathogen interactions. J Leukoc Biol (2005) 0.92
Genetic and genomic analyses of host-pathogen interactions in malaria. Trends Parasitol (2009) 0.92
Influence of Slc11a1 on the outcome of Salmonella enterica serovar Enteritidis infection in mice is associated with Th polarization. Infect Immun (2006) 0.92
Nucleotide binding and nucleotide hydrolysis properties of the ABC transporter MRP6 (ABCC6). Biochemistry (2002) 0.91
The C3H/HeJ inbred mouse is a model of vesico-ureteric reflux with a susceptibility locus on chromosome 12. Kidney Int (2010) 0.91
Iron transporter Nramp2/DMT-1 is associated with the membrane of phagosomes in macrophages and Sertoli cells. Blood (2002) 0.89
Interleukin-15 enhances innate and adaptive immune responses to blood-stage malaria infection in mice. Infect Immun (2005) 0.89
Triaminotriazine DNA helicase inhibitors with antibacterial activity. Bioorg Med Chem Lett (2005) 0.89
[Cellular angiofibroma, angiomyofibroblastoma and aggressive angiomyxoma: members of a spectrum of genital stromal tumours?]. Ann Pathol (2002) 0.89
Transmembrane topology of the mammalian Slc11a2 iron transporter. Biochemistry (2009) 0.89
Intracellular Leishmania: your iron or mine? Trends Microbiol (2007) 0.89
A novel R416C mutation in human DMT1 (SLC11A2) displays pleiotropic effects on function and causes microcytic anemia and hepatic iron overload. Blood Cells Mol Dis (2006) 0.88
Cardiac failure in C5-deficient A/J mice after Candida albicans infection. Infect Immun (2006) 0.88
Conformational change induced by ATP binding in the multidrug ATP-binding cassette transporter BmrA. Biochemistry (2008) 0.88
Genetic control of susceptibility to infection with Candida albicans in mice. PLoS One (2011) 0.88
A novel hypomorphic Looptail allele at the planar cell polarity Vangl2 gene. Dev Dyn (2011) 0.88
A two-locus system controls susceptibility to colitis-associated colon cancer in mice. Oncotarget (2010) 0.88
Rescue of the neural tube defect of loop-tail mice by a BAC clone containing the Ltap gene. Genomics (2003) 0.87
Total diet study on pesticide residues in France: levels in food as consumed and chronic dietary risk to consumers. Environ Int (2012) 0.87
Molecular and cellular mechanisms underlying iron transport deficiency in microcytic anemia. Blood (2004) 0.86
Adenosine triphosphate depletion of erythrocytes simulates the phenotype associated with pyruvate kinase deficiency and confers protection against Plasmodium falciparum in vitro. J Infect Dis (2009) 0.86
Iron chelators modulate the fusogenic properties of Salmonella-containing phagosomes. Proc Natl Acad Sci U S A (2003) 0.86
Functional characterization of the E399D DMT1/NRAMP2/SLC11A2 protein produced by an exon 12 mutation in a patient with microcytic anemia and iron overload. Blood Cells Mol Dis (2005) 0.85
Mutational analysis of conserved aromatic residues in the A-loop of the ABC transporter ABCB1A (mouse Mdr3). FEBS Lett (2007) 0.85
Analysis of catalytic carboxylate mutants E552Q and E1197Q suggests asymmetric ATP hydrolysis by the two nucleotide-binding domains of P-glycoprotein. Biochemistry (2003) 0.85
An expanding role of Vangl proteins in embryonic development. Curr Top Dev Biol (2012) 0.84
Genetic and functional characterization of the mouse Trl3 locus in defense against tuberculosis. J Immunol (2009) 0.84
Global cellular changes induced by Legionella pneumophila infection of bone marrow-derived macrophages. Immunobiology (2011) 0.84
Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin. Antimicrob Agents Chemother (2010) 0.84
The impact of genomics on the analysis of host resistance to infectious disease. Microbes Infect (2006) 0.83
An N-ethyl-N-nitrosourea (ENU)-induced dominant negative mutation in the JAK3 kinase protects against cerebral malaria. PLoS One (2012) 0.83
Increased resistance to malaria in mice with methylenetetrahydrofolate reductase (Mthfr) deficiency suggests a mechanism for selection of the MTHFR 677C>T (c.665C>T) variant. Hum Mutat (2014) 0.83
Competition of bacteriophage polypeptides with native replicase proteins for binding to the DNA sliding clamp reveals a novel mechanism for DNA replication arrest in Staphylococcus aureus. Mol Microbiol (2006) 0.82
Structural and functional asymmetry of the nucleotide-binding domains of P-glycoprotein investigated by attenuated total reflection Fourier transform infrared spectroscopy. J Biol Chem (2001) 0.82
Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutation. Blood (2014) 0.82